News
As you age, maintaining a daily habit of walking can prevent cognitive decline, especially for those most at risk, a new ...
New research builds on evidence that diet, certain brain training exercises and physical activity can delay the decline of ...
(Reuters) -Swiss drugmaker Roche Holding plans to investigate whether an experimental medicine can delay or prevent Alzheimer ...
Roche’s Alzheimer’s disease therapy has continued to show benefit for patients after 28 weeks in a long-term extension study.
Without the receptor, ADGRG1, the microglia barely nibbled on the toxic protein. Using a mouse model of Alzheimer's disease, ...
Breakthrough as two FDA-approved drugs are found to reverse Alzheimer’s — including restoring memory
Researchers have found that a pair of drugs can not only slow down Alzheimer’s disease but actually reverse it and restore memory in mice.
Acknowledging the limits of disease-modifying drugs like Leqembi and Kisunla, companies like Bristol Myers Squibb, Acadia, ...
5h
News-Medical.Net on MSNUCSF discovery points to new strategies for Alzheimer's treatmentUCSF scientists have discovered how microglia engulf and break down amyloid beta, a protein that builds up in Alzheimer's, ...
These five upcoming data drops could usher in more effective and convenient therapies for Alzheimer’s disease and open up ...
17d
MedPage Today on MSNManaging Psychiatric and Behavioral Problems With Alzheimer's DiseaseAs Alzheimer's disease progresses, behavioral and psychiatric issues become common, distressing, and even dangerous for ...
Roche Holding AG plans to test whether an experimental medicine can prevent Alzheimer’s disease symptoms in high-risk people, ...
(Reuters) -Swiss drugmaker Roche Holding plans to test whether an experimental medicine can prevent Alzheimer's disease ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results